Oncology

Papers
(The H4-Index of Oncology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Metastatic Prostate Cancer: Treatment Options46
Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma34
The Emergence of Artificial Intelligence within Radiation Oncology Treatment Planning28
A Review of Applications of Machine Learning in Mammography and Future Challenges22
Cholangiocarcinoma Evaluation via Imaging and Artificial Intelligence18
Non-Muscle Invasive Bladder Cancer with Variant Histology: Biological Features and Clinical Implications18
Current Status and Quality of Machine Learning-Based Radiomics Studies for Glioma Grading: A Systematic Review17
Early Changes in Alpha-Fetoprotein Are a Useful Predictor of Efficacy of Atezolizumab plus Bevacizumab Treatment in Patients with Advanced Hepatocellular Carcinoma17
The Role of the Albumin-Bilirubin Score for Predicting the Outcomes in Japanese Patients with Advanced Hepatocellular Carcinoma Treated with Ramucirumab: A Real-World Study16
High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases15
Lenvatinib-Induced Tumor-Related Hemorrhages in Patients with Large Hepatocellular Carcinomas14
The Use of Patient-Reported Outcome Measures in Phase I Oncology Clinical Trials14
BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma14
Molecular Biomarkers according to Primary Tumor Location in Colorectal Cancer: Current Standard and New Insights14
0.031677961349487